ADDED
As of September 30, 2025, the Company had not yet commenced operations.
Liquidity and Capital Sources As of September 30, 2025 and December 31, 2024, the Company had cash balances of $ 859,596 and $ 25,000 , respectively.
The working capital was a surplus of $ 937,584 as of September 30, 2025, and a deficit of $ 548,570 as of December 31, 2024, excluding deferred offering costs.
Net Income (Loss) per Ordinary Share Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period.
As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented.
As of September 30, 2025 and December 31, 2024, the Company had $ 859,596 and $ 25,000 , respectively, in cash.
13 Accordingly, at September 30, 2025, the Class A ordinary shares subject to redemption reflected in the condensed balance sheets are reconciled in the following table: Schedule of shares subject to redemption Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants ( 3,808,800 ) Less: Public Shares issuance costs ( 18,239,185 ) Add: Remeasurement of carrying value to redemption value 28,926,206 Class A ordinary shares subject to possible redemption September 30, 2025 $ 282,878,221 As of December 31, 2024, there were no Class A ordinary shares issued or outstanding.
As of September 30, 2025 and December 31, 2024, there was a $nil and $ 74,200 outstanding balance owed to the Sponsor respectively.
The entity affiliated with the President of the Company billed a consulting fee of $ 90,000 during the period from January 11, 2024 (inception) through September 30, 2024.
18 Warrants As of September 30, 2025 and December 31, 2024, there were 21,910,056 warrants, including 13,800,000 Warrants and 8,110,056 Private Placement Warrants, and nil 0 outstanding, respectively.
REMOVED
As of June 30, 2025, the Company had not yet commenced operations.
Liquidity and Capital Sources As of June 30, 2025, and December 31, 2024, the Company had cash balances of $ 951,408 and $ 25,000 , respectively.
The working capital was a surplus of $ 1,060,324 as of June 30, 2025, and a deficit of $ 548,570 as of December 31, 2024, excluding deferred offering costs.
Net Loss per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period.
As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.
As of June 30, 2025 and December 31, 2024, the Company had $ 951,408 and $ 25,000 , respectively, in cash.
Accordingly at June 30, 2025, the Class A ordinary shares subject to redemption reflected in the balance sheets are reconciled in the following table: Schedule of shares subject to redemption Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants ( 3,808,800 ) Less: Public Shares issuance costs ( 18,239,185 ) Add: Remeasurement of carrying value to redemption value 26,001,398 Class A ordinary shares subject to possible redemption June 30, 2025 $ 279,953,413 As of December 31, 2024, there were no Class A ordinary shares issued or outstanding.
As of June 30, 2025 and December 31, 2024, there was nil and $ 74,200 outstanding balance owed to the sponsor respectively.
The entity affiliated with the President of the Company billed a consulting fee of $ 75,000 during the period January 11, 2024 to June 30, 2024.
18 Warrants As of June 30, 2025 and December 31, 2024, there were 21,910,056 warrants, including 13,800,000 Warrants and 8,110,056 Private Placement Warrants, and nil 0 outstanding respectively.